Sensor system manufacturer Adaptive Methods said last week that it has inked an option agreement for biosensor technology co-invented by researchers at the University of New Mexico's Health Sciences Center and Sandia National Labs.
Under the agreement, Adaptive Methods may now obtain an exclusive, worldwide license to manufacture and sell products incorporating the biosensor technology, which enables the detection of bio-agents such as bacteria, viruses, and toxins at low levels and in near-real time.
Adaptive Methods plans to commercialize the technology for use in the healthcare, homeland defense, and military sectors.
Financial terms of the agreement were not disclosed.
The company said that the option agreement was an important step toward forming "a long-term partnership" with UNMHSC, Sandia, and STC.UNM, the technology-transfer arm for UNM.
Lisa Kuuttila, president and CEO of STC.UNM, told BTW this week that the biosensor technology was "a collaboration between UNM, which had the original concept for the technology, and Sandia, whose contribution was on the hardware side."
A previously signed memorandum of understanding between STC.UNM and Sandia states that the organizations determine who takes the lead on tech-transfer deals on a case-by-case basis as IP results from research collaborations.
In this case, STC.UNM acted as the lead institution because the primary inventor on the technology was Richard Larson, vice president for research at UNMHSC, Kuuttila said. She added that any future royalties from products incorporating the biosensor technology would be split between UNM and Sandia.
A provisional patent application has been filed for the technology, Kuuttila said.
Adaptive Methods, based in Centreville, Va., develops advanced sensor processing and computing architecture products for surveillance, security, and military combat systems.